首页 › 基金 › Jones Hill Capital LP › ACRS
Jones Hill Capital LP 对 ACRS 的持仓历史
ACLARIS THERAPEUTICS INC · 医疗保健
Jones Hill Capital LP 在 Q3 2026 的 13F 申报中披露持有 ACRS(ACLARIS THERAPEUTICS INC)2,504,651 股,市值约 US$13.2M,约占其申报组合的 2.24%,在其申报持仓中市值排名第 15 位。 Jones Hill Capital LP 最近 2 个申报季度中有 2 个季度披露了 ACRS 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Jones Hill Capital LP 对 ACRS 的持仓演变
Jones Hill Capital LP 于 Q2 2026 首次披露 ACRS 持仓:1,759,492 股(约 US$9.3M)。 该持仓在 Q3 2026 达到峰值 2,504,651 股,市值约 US$13.2M。 在 2 次申报中,Jones Hill Capital LP 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 2,504,651 股、市值约 US$13.2M,环比增持 745,159 股。。 持仓曾出现大幅变动:Q3 2026 增持约 42% (随后一个季度股价下跌 25%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 1.76M | $9.31M | 新进 |
| Q3 2026 | 2.50M | $13.17M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ACRS 与 13F 数据
ACRS(ACLARIS THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 44 只申报持有 ACRS,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$67.3M), BML Capital Management, LLC (US$57.6M), Deep Track Capital, LP (US$49.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ACRS 的基金
- RA CAPITAL MANAGEMENT, L.P. 12.72M 股 · $67.30M · Q2 2026
- BML Capital Management, LLC 10.96M 股 · $57.62M · Q3 2026
- Deep Track Capital, LP 9.35M 股 · $49.44M · Q2 2026
- Vivo Capital, LLC 6.69M 股 · $35.21M · Q3 2026
- Frazier Life Sciences Management, L.P. 4.93M 股 · $26.06M · Q2 2026
- Rock Springs Capital Management LP 4.33M 股 · $22.91M · Q2 2026
- Decheng Capital LLC 4.04M 股 · $21.38M · Q2 2026
- Kalehua Capital Management LLC 1.83M 股 · $9.64M · Q3 2026
- Palo Alto Investors LP 1.61M 股 · $8.54M · Q2 2026
- MPM BioImpact LLC 1.04M 股 · $5.51M · Q2 2026
- Aldebaran Capital, LLC 936.18K 股 · $4.92M · Q3 2026
- Three Bridge Wealth Advisors, LLC 714.82K 股 · $3.76M · Q3 2026
更多关于 Jones Hill Capital LP
常见问题
How long has Jones Hill Capital LP held ACRS?
Jones Hill Capital LP has disclosed ACRS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Jones Hill Capital LP's current position in ACRS?
As of Q3 2026, Jones Hill Capital LP holds 2.50M shares of ACRS (ACLARIS THERAPEUTICS INC), valued at $13.17M, representing 2.24% of its reported portfolio and ranking #15.
Has Jones Hill Capital LP been buying or selling ACRS?
In the latest 13F filing (Q3 2026), Jones Hill Capital LP increased its position in ACRS. The position peaked in Q3 2026 at 2.50M shares.
Which other funds hold ACRS?
Other major institutional holders of ACRS include RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, Deep Track Capital, LP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.